Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks' gestation: a case series and systematic review of the literature

J Kiley, A Turner, C Nosal, M Beestrum… - The European Journal …, 2022 - Taylor & Francis
Purpose Under some circumstances, individuals choose to undergo pregnancy termination
for foetal anomalies in the second half of pregnancy. This report provides objective …

Short versus standard mifepristone and misoprostol regimen for second-and third-trimester termination of pregnancy for fetal anomaly

A Sharp, K Navaratnam, P Abreu… - Fetal Diagnosis and …, 2016 - karger.com
Background: Termination of pregnancy requires a 48-hour 'window'between mifepristone
and misoprostol. Shorter durations have been used in first-trimester termination, but there …

Factors influencing the duration of termination of pregnancy for fetal anomaly with mifepristone in combination with misoprostol

T Reischer, I Limbach, A Catic, K Niedermaier… - Journal of Clinical …, 2023 - mdpi.com
This study's aim was to determine relevant factors that influence the time interval between
first induction and fetal expulsion in late termination of pregnancy (TOP) and TOP after …

Dosing interval between mifepristone and misoprostol in second and third trimester termination

N Prodan, J Breisch, M Hoopmann, H Abele… - Archives of Gynecology …, 2019 - Springer
Objective To compare several strategies for second trimester labor induction for termination
of pregnancy (TOP) using misoprostol and mifepristone and to determine which one is more …

One-and 2-day mifepristone–misoprostol intervals are both effective in medical termination of second-trimester pregnancy

O Heikinheimo, S Suhonen, M Haukkamaa - Reproductive BioMedicine …, 2004 - Elsevier
Termination of pregnancy because of fetal anomaly requires the utmost clinical sensitivity
and individualized patient care. This study compared the efficacy of a 1-day mifepristone …

346 Efficacy and safety of mifepristone and sublingual misoprostol for second trimester medical abortion. A prospective study

N Peitsidis, G Kapetanios, I Kalogiannidis… - European Journal of …, 2022 - ejog.org
Background: Second trimester pregnancy termination is part of comprehensive women's
care. This study aimed to evaluate the efficacy and safety of mifepristone combined with …

Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: worth the effort

JE Dickinson, P Brownell, K McGINNIS… - Australian and New …, 2010 - Wiley Online Library
Objective: To determine the impact on the process of second trimester medical termination
for fetal abnormality following the introduction of adjunctive mifepristone in an Australian …

Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; …

MT Verhulsdonk, DN Papatsonis… - Nederlands Tijdschrift …, 2007 - europepmc.org
Objective To evaluate the method of mifepristone and misoprostol for pregnancy termination
during the second trimester or for intrauterine foetal death during the second or third …

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review

FA Abubeker, A Lavelanet, MI Rodriguez, C Kim - BMC women's health, 2020 - Springer
Background A wide range of drugs have been studied for first trimester medical abortion.
Studies evaluating different regimens, including combination mifepristone and misoprostol …

Interruption of nonviable pregnancies of 24–28 weeks' gestation using medical methods

JB Perritt, A Burke, AB Edelman - Contraception, 2013 - Elsevier
The need to interrupt a pregnancy between 24 and 28 weeks of gestation is uncommon and
is typically due to fetal demise or lethal anomalies. Nonetheless, treatment options become …